Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL612164 | 0.86 | CYP2C19 (0.38) | NAAACYP2C19 | |
| SCHEMBL28012006 | 0.86 | CYP2C19 (0.38) | NAAACYP2C19 | |
| SCHEMBL16457292 | 0.86 | CYP2C19 (0.38) | NAAACYP2C19 | |
| SCHEMBL18825657 | 0.85 | NAAA (0.37) | NAAASMN1; SMN2CYP2C19 | |
| SCHEMBL11408977 | 0.82 | CYP2C19 (0.36) | NAAASMN1; SMN2CYP2C19 | |
| SCHEMBL9153121 | 0.82 | NAAA (0.61) | NAAASMN1; SMN2 | |
| SCHEMBL1336805 | 0.81 | GPBAR1 (0.32) | GPBAR1 | |
| SCHEMBL698620 | 0.81 | CYP2C19 (0.35) | NAAACYP2C19 | |
| SCHEMBL4063062 | 0.79 | EPHX1 (0.32) | CYP2C19 | |
| SCHEMBL614025 | 0.79 | CYP19A1 (0.33) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 372 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CHICAGO ATLANTIC ADMIN, LLC | 2021-07-15 | — | — | US | claimed |
| EP-1924148-B1 | CONFECTIONERY COMPOSITION INCLUDING AN ELASTOMERIC COMPONENT, A COOKED SACCHARIDE COMPONENT, AND A SENSATE | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2016-07-20 | — | — | EP | claimed |
| US-20160128944-A1 | COATED PARTICLES AND COMPOSITIONS COMPRISING SAME | VYOME THERAPEUTICS LIMITED (IN) | 2016-05-12 | — | — | US | claimed |
| US-9320705-B2 | Sensation modifying topical composition foam | FOAMIX PHARMACEUTICALS LTD. (IL) | 2016-04-26 | — | — | US | claimed |
| US-20120237453-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | FOAMIX LTD. (IL) | 2012-09-20 | — | — | US | claimed |
| US-20100129489-A1 | SENSATE-PLATED SANDING COMPOSITION AND PRODUCTS MADE THEREFROM | INTERCONTINENTAL GREAT BRANDS LLC | 2010-05-27 | — | — | US | claimed |
| CN-101346072-A | Compositions for oral or transdermal delivery providing a heating sensation | CADBURY ADAMS USA LLC (US) | 2009-01-14 | — | — | CN | claimed |
| US-20080253973-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | FOAMIX LTD. (IL) | 2008-10-16 | — | — | US | claimed |
| US-20070148103-A1 | Compositions providing a heating sensation for oral or dermal delivery | CADBURY ADAMS USA, LLC. | 2007-06-28 | — | — | US | claimed |
| EP-3869971-B1 | CENTER-FILLED CONFECTIONERY PRODUCT; COATED PRODUCT; AND METHODS OF MAKING | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-4380553-A1 | STABILISED COMPOSITIONS | Rumin8 Pty Ltd (AU) | 2024-06-12 | — | — | EP | disclosed |
| CN-117979961-A | Stabilized compositions | 鲁米兰特私人有限公司 | 2024-05-03 | — | — | CN | disclosed |
| US-11930830-B2 | System and method of forming multilayer confectionery | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2024-03-19 | — | — | US | disclosed |
| US-11896028-B2 | Dual-textured confectionery; and methods of making the same | INTERCONTINENTAL GREAT BRANDS LLC (US) | 2024-02-13 | — | — | US | disclosed |
| US-20060280834-A1 | Center-filled chewing gum composition | CADBURY ADAMS USA, LLC. | 2006-12-14 | — | — | US | disclosed |
| US-20060280837-A1 | Multi-modality sensations in chewing gum compositions | CADBURY ADAMS USA LLC. | 2006-12-14 | — | — | US | disclosed |
| US-20060280836-A1 | Multi-modality tastes in chewing gum compositions | CADBURY ADAMS USA LLC. | 2006-12-14 | — | — | US | disclosed |
| US-20060280835-A1 | Multi-modality flavored chewing gum compositions | CADBURY ADAMS USA LLC. | 2006-12-14 | — | — | US | disclosed |
| US-20060263476-A1 | Center-filled chewing gum with barrier layer | CADBURY ADAMS USA, LLC. | 2006-11-23 | — | — | US | disclosed |
| US-20060263475-A1 | Center-filled chewing gum composition | CADBURY ADAMS USA, LLC. | 2006-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070148103-A1 | Compositions providing a heating sensation for oral or dermal delivery | TAS2R8, TAS2R60, TAS2R20 | NAAA 1248/4885SMN1; SMN2 1011/4885CYP2C19 1261/4885 |
| US-20080253973-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | TRPA1, GPR35, TRPV1 | NAAA 1587/4885SMN1; SMN2 1331/4885CYP2C19 1460/4885 |
| US-20120237453-A1 | SENSATION MODIFYING TOPICAL COMPOSITION FOAM | TRPA1, GPR35, TRPV1 | NAAA 1587/4885SMN1; SMN2 1331/4885CYP2C19 1460/4885 |
| US-20210212983-A1 | ORAL CANNABINOID DELIVERY FORMULATIONS WITH MOUTHFEEL EXPERIENCE ENHANCERS | CNR2, CNR1, CPNE4 | NAAA 2025/4885SMN1; SMN2 1260/4885CYP2C19 477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.